Kenneth Sim - Astrana Health Executive Chairman of the Board
| AMEHDelisted Stock | USD 40.82 0.88 2.11% |
Chairman
Dr. Kenneth Sim, M.D., is an Executive Chairman of the Board of Apollo Medical Holdings, Inc. Dr. Sim was the Executive Chairman of the Board since December 2017. Dr. Sim was a member of NMMs board of directors since 2006 and was the boards chairman since 2013. Dr. Sim is also the Chairman of the board of directors of Allied Physicians of California IPA since 2014. Dr. Sim is a Fellow of the American College of Surgeons and was awarded the Independent Physician Leadership Award in 2014 by the Los Angeles County Medical Association since 2017.
| Age | 64 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 626 282 0288 |
| Web | https://www.apollomed.net |
Astrana Health Management Efficiency
The company has return on total asset (ROA) of 0.0626 % which means that it generated a profit of $0.0626 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0976 %, meaning that it created $0.0976 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 229.36 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Astrana Health has a current ratio of 2.44, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Astrana Health until it has trouble settling it off, either with new capital or with free cash flow. So, Astrana Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Astrana Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Astrana to invest in growth at high rates of return. When we think about Astrana Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 14 records | CHAIRMAN Age | ||
| Bruce Shear | Acadia Healthcare | 62 | |
| Mark Heaney | Addus HomeCare | 58 | |
| Leo Higdon | Encompass Health Corp | 74 | |
| Joey Jacobs | Acadia Healthcare | 63 | |
| Christopher Laitala | Surgery Partners | 42 | |
| Alan Miller | Universal Health Services | 86 | |
| Rocco Ortenzio | Select Medical Holdings | 91 | |
| Roy Christensen | The Ensign Group | 84 | |
| Robert Ortenzio | Select Medical Holdings | 66 | |
| Henry Esber | InnovAge Holding Corp | 78 | |
| Wayne DeVeydt | Surgery Partners | 54 | |
| Daniel McCartney | Healthcare Services Group | 63 | |
| Donald Washburn | Amedisys | 73 | |
| Ronald LaBorde | Amedisys | 58 | |
Management Performance
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 |
Astrana Health Leadership Team
Elected by the shareholders, the Astrana Health's board of directors comprises two types of representatives: Astrana Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Astrana. The board's role is to monitor Astrana Health's management team and ensure that shareholders' interests are well served. Astrana Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Astrana Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Li Yu, Director | ||
| WaiChow MD, Chief Officer | ||
| Suresh Nihalani, Independent Director | ||
| Joseph Molina, Director | ||
| Mihir Shah, CFO | ||
| Ernest Bates, Director | ||
| Kenneth Sim, Executive Chairman of the Board | ||
| Linda Marsh, Director | ||
| Thomas Lam, Director | ||
| Carlos MD, Chief Texas | ||
| Hing Ang, COO | ||
| Jeremy MD, Chief Officer | ||
| Brandon Sim, CoChief Officer | ||
| David Schmidt, Independent Director | ||
| Michael Eng, Director | ||
| William Abbott, CFO | ||
| Warren Hosseinion, CEO, Director | ||
| Gary Augusta, Executive Chairman | ||
| John Chiang, Director | ||
| Neil Ahuja, President Solutions | ||
| Edward Schreck, Director | ||
| Mitchell Kitayama, Director | ||
| Kenneth MD, Executive Chairman | ||
| Chandan Basho, CFO Officer | ||
| Albert Young, Co-Chief Medical Officer | ||
| Mark Fawcett, Independent Director | ||
| Yubin Park, Chief Officer | ||
| Dinesh MD, Chief Officer | ||
| John Vong, Chief Officer | ||
| Eric Chin, CFO | ||
| Adrian Vazquez, Chief Medical Officer | ||
| Chan Basho, Chief CFO | ||
| MPH MD, CoCEO President |
Astrana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Astrana Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X |
Pair Trading with Astrana Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Astrana Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astrana Health will appreciate offsetting losses from the drop in the long position's value.Moving against Astrana Stock
| 0.73 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.56 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
| 0.52 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.51 | TRCA | Twin Ridge Capital | PairCorr |
| 0.46 | T | ATT Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Astrana Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Astrana Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Astrana Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Astrana Health to buy it.
The correlation of Astrana Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Astrana Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Astrana Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Astrana Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Astrana Health information on this page should be used as a complementary analysis to other Astrana Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |